Dr. Mixson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15620 Thistlebridge Dr
Rockville, MD 20853Phone+1 410-706-3223
Summary
- Dr. Archibald Mixson, based in Baltimore, specializes in Internal Medicine and Endocrinology. He received his medical education and training from Emory University and the National Institutes of Health Clinical Center, specializing in Endocrinology, Diabetes, and Metabolism. He has held positions as a professor at the University of Maryland School of Medicine and trained in Internal Medicine and Endocrinology at Emory University School of Medicine and NIH, respectively. Dr. Mixson's medical experience includes work on solid tumors such as breast cancer, thyroid hormone resistance, and nucleic acid delivery platforms. He has published numerous nationally recognized research articles and received multiple awards. He has also been granted seven U.S. and European patents, and is the founder of Sirnaomics, Inc, a company specializing in siRNA for improved wound healing and cancer treatment.
Education & Training
- NIH Clinical CenterPost-Doctoral Fellowship, 1992 - 1995
- National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1989 - 1992
- National Institutes of Health Clinical CenterPost-Doctoral Fellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1989
- Emory University School of MedicineResidency, Internal Medicine, 1981 - 1983
- Emory University Hospital1980 - 1982
- Emory University School of MedicineInternship, Pediatrics, 1979 - 1980
- Emory University School of MedicineClass of 1979
- Vanderbilt UniversityB.A, Math, Chemistry, 1970 - 1974
Certifications & Licensure
- MD State Medical License 1987 - 2025
- GA State Medical License 1983 - 1987
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Awarded 7 US and European Patents
- Their lead product utilizes an HK peptide as a carrier of siRNA for improved wound healing Founder, Sirnaomics, Inc (Bethesda, MD/Suzhou, CH), 2007
- Selected to Marquis Who’s Who in the World 2009
- Join now to see all
Publications & Presentations
PubMed
- 1 citationspH modification of gel mobility shift improves polyplex selection In Vivo.Q Leng, A Anand, A James Mixson
Biochemical and Biophysical Research Communications. 2024-12-17 - pH-Dependent Non-Covalent Release of Chemotherapy from Carriers.Qixin Leng, Aishwarya Anand, Archibald James Mixson
Discovery Medicine. 2024-03-01 - 1 citationsDelivery of mRNA with Histidine-Lysine Peptides.Qixin Leng, Jiaxi He, Aishwarya Anand, A James Mixson
Methods in Molecular Biology. 2024-01-01
Journal Articles
- Gene therapy with p53 inhibits human breast cancer in vivo.Xu M, Kumar D, Stass S, and Mixson AJ, Molecular Genetics and Metabolism
- Recent advances in systemic gene therapy with p53.Chen QR and Mixson AJ, Frontiers in Bioscience
- Liposomes complexed to angiostatin and endostatin inhibit breast cancer in nude mice.Chen QR, Kumar D, Stass SA, and Mixson AJ, Cancer Research
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Raf-1 siRNA Inhibits Tumor Growth In Vivo.Leng Q and Mixson AJ, 8th Annual Meeting of the American Society of Gene Therapy
- Direct Measurements of Mechanical Properties of Condensed DNA for Gene Delivery Using Optical Tweezers.Seog J, Lee A, Karcz A, Tie C, Sucayan S, Kahn J, Mixson A, International Conference of Young Researchers on Advanced Materials
- Modified HK siRNA Polyplexes with Improved Pharmacokinetics Enhance Tumor Inhibition.Chou ST, Leng Q, Scaria P, Mixson AJ, American Society of Cellular and Gene Therapy 15th Annual Meeting
- Join now to see all
Lectures
- Liposomal Delivery Systems for Central and Peripheral Hyperalimentation solutions.Cape Sunion Beach, Greece
Other
- Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy.US patent
- Cationic vehicle: DNA complexes and their use in gene therapy.#EPO819758B1
- Branched Histidine copolymers and methods for using the same.US Patent
- Join now to see all
Grant Support
- Developing nanoplexes for RNAi-expressing plasmidsNational Institutes of Health2019–2024
- Identification of Structural Features of HK Polyplexes for Improved siRNA Delivery to TumorsNational Institutes of Health, NCI2009–2014
- Gene Delivery of p53 in a tumor-bearing mouse modelNational Insitutes of Health, NCI2004–2009
- HK polymers as transfection reagents for siRNA deliveryNational Institutes of Health, NIGMS2005–2006
- Inhibition of Intracerebral Gliomas with DNAzymes in complex with a histidine-lysine polymerNational Institutes of Health, NCI2004–2005
- Systemic Delivery of p53 Inhibits Breast CancerNational Institutes of Health, NCI1997–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: